Theralase Technologies Inc.

News & Events

Press Releases

In The Media

1. Theralase Completes Annual General and Special Meeting

   Newsfile JUN 12, 2025 7:00 AM EDT
   Toronto, Ontario--(Newsfile Corp. - June 12, 2025) -  Theralase® Technologies Inc. ...
   READ ARTICLE

2. Theralase Annual General Meeting

   Newsfile JUN 5, 2025 7:00 AM EDT
   Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT...
   READ ARTICLE

3. Theralase(R) 1Q2025 Financial Statements

   Newsfile MAY 30, 2025 7:00 AM EDT
   Toronto, Ontario--(Newsfile Corp. - May 30, 2025) - Theralase® Technologies Inc. ( TSXV: TLT...
   READ ARTICLE

4. CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025

   Newsfile MAY 29, 2025 4:30 PM EDT
   Radiation-Activated Rutherrin(R) Versus Radiation Alone in Preclinical Cancer Models to be Presen...
   READ ARTICLE

5. Theralase to Present Groundbreaking Research at ASTRO 2025

   Newsfile MAY 28, 2025 7:00 AM EDT
   Radiation-Activated Rutherrin(R) Shown to Be 100 Times More Effective Than Radiation Alone in Pre...
   READ ARTICLE

6. Theralase Provides Corporate Update

   Newsfile MAY 20, 2025 7:00 AM EDT
   Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Theralase® Technologies Inc. (TSXV: TLT...
   READ ARTICLE

7. Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association

   Newsfile MAY 5, 2025 7:00 AM EDT
   Toronto, Ontario--(Newsfile Corp. - May 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT)...
   READ ARTICLE

8. Theralase Discovers New Mechanism of Action of Lead Drug

   Newsfile APR 28, 2025 7:00 AM EDT
   Theralase(R) Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar...
   READ ARTICLE

9. Theralase(R) Closes Non-Brokered Private Placement

   Newsfile APR 14, 2025 4:22 PM EDT
   Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - Theralase® Technologies Inc. (TSXV: T...
   READ ARTICLE

10. Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments

    Newsfile APR 10, 2025 7:00 AM EDT
    Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus ...
    READ ARTICLE